Marko Salmi - UTU Research Portal

Marko Salmi

- Professor,
Institute of Biomedicine (Faculty of Medicine)
- ,
InFLAMES Flagship (Faculty of Medicine)

masalmi@utu.fi

+358 29 450 4380

+358 50 338 5678

Publications

9 of 10

Tuberkuloosihoitoa potilaan genotyypin mukaan? (2012)
- Duodecim
Marko Salmi
(D1 Article in a professional journal)
Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study (2012)
- Clinical Cancer Research
Sihto H, Bohling T, Kavola H, Koljonen V, Salmi M, Jalkanen S, Joensuu H
(A1 Refereed original research article in a scientific journal)
Tuumorinsisäinen vaihtelu vaikeuttaa täsmälääkitystä (2012)
- Duodecim
Marko Salmi
(D1 Article in a professional journal)
Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients (2012)
- International Journal of Cancer
Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression (2011)
- European Journal of Immunology
Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemela J, Laurila JP, Elima K, Jalkanen S, Salmi M
(A1 Refereed original research article in a scientific journal)
Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium (2011)
- Journal of Immunology
Shetty S, Weston CJ, Oo YH, Westerlund N, Stamataki Z, Youster J, Hubscher SG, Salmi M, Jalkanen S, Lalor PF, Adams DH
(A1 Refereed original research article in a scientific journal)
Different role of CD73 in leukocyte trafficking via blood and lymph vessels (2011)
- Blood
Algars A, Karikoski M, Yegutkin GG, Stoitzner P, Niemela J, Salmi M, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread (2011)
- FEBS Letters
Salmi M, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Identification of Two Imidazole Binding Sites and Key Residues for Substrate Specificity in Human Primary Amine Oxidase AOC3 (2011)
- Biochemistry
Elovaara H, Kidron H, Parkash V, Nymalm Y, Bligt E, Ollikka P, Smith DJ, Pihlavisto M, Salmi M, Jalkanen S, Salminen TA
(A1 Refereed original research article in a scientific journal)
Lymphatic expression of CLEVER-1 in breast cancer and its relationship with lymph node metastasis (2011)
- Analytical Cellular Pathology
Ammar Aula, Mohammed Rabab, Salmi Marko, Pepper Michael, Paish Emma, Ellis Ian, Martin Stewart
(A1 Refereed original research article in a scientific journal)
Regulation of Mucosal Addressin Cell Adhesion Molecule 1 Expression in Human and Mice by Vascular Adhesion Protein 1 Amine Oxidase Activity (2011)
- Hepatology
Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH
(A1 Refereed original research article in a scientific journal)
SHARPIN is an endogenous inhibitor of beta 1-integrin activation (2011)
- Nature Cell Biology
Rantala JK, Pouwels J, Pellinen T, Veltel S, Laasola P, Mattila E, Potter CS, Duffy T, Sundberg JP, Kallioniemi O, Askari JA, Humphries MJ, Parsons M, Salmi M, Ivaska J
(A1 Refereed original research article in a scientific journal)
Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer (2011)
- Blood
Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors (2010)
- Brain Pathology
Puputti M, Tynninen O, Pernila P, Salmi M, Jalkanen S, Paetau A, Sihto H, Joensuu H
(A1 Refereed original research article in a scientific journal)
Regulation of MAdCAM-1 expression in human hepatic endothelium by VAP-1 amine oxidase activity (2010)
- Hepatology
Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH
(A1 Refereed original research article in a scientific journal)
Small-Molecule Inhibitors of Vascular Adhesion Protein-1 Reduce the Accumulation of Myeloid Cells into Tumors and Attenuate Tumor Growth in Mice (2010)
- Journal of Immunology
Marttila-Ichihara F, Castermans K, Auvinen K, Egbrink MGAO, Jalkanen S, Griffioen AW, Salmi M
(A1 Refereed original research article in a scientific journal)
Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation (2009)
- European Journal of Immunology
Karikoski M, Irjala H, Maksimow M, Miiluniemi M, Granfors K, Hernesniemi S, Elima K, Moldenhauer G, Schledzewski K, Kzhyshkowska J, Goerdt S, Salmi M, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate (2009)
- Blood
Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S
(A1 Refereed original research article in a scientific journal)
The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. (2009)
- Blood
Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S
(A1 Refereed original research article in a scientific journal)
Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection (2008)
- International Journal of Immunopathology and Pharmacology
Martelius T, Salmi M, Krogerus L, Loginov R, Schoultz M, Karikoski M, Miiluniemi M, Soots A, Hockerstedt K, Jalkanen S, Lautenschlager I
(A1 Refereed original research article in a scientific journal)